R.D. Bulbrook
- Cancer Research top 5%
- Breast Cancer Treatment Studies 6
- Oncology top 5%
- Cancer Risks and Factors 9
- Biochemistry top 5%
- Genetics top 5%
- Estrogen and related hormone effects 14
-
- Breast Lesions and Carcinomas 3
-
- Hormonal and reproductive studies 9
- Hormonal Regulation and Hypertension 4
- Growth Hormone and Insulin-like Growth Factors 3
-
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- J.L. HaywardL.V. CrawfordD. PimJack CuzickJ BorehamNicholas WaldRosemary R. MillisM.A. Chaudary
- Cited by
- Cancer ResearchOncologyBiochemistry
- Journals
- The Lancet (12 papers)Journal of Endocrinology (10 papers)International Journal of Cancer (6 papers)
- Partner nations
- United KingdomNetherlandsDenmark
In The Last Decade
R.D. Bulbrook
49 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 478
- Oncology 774
- Biochemistry 137
- Genetics 528
- Pathology and Forensic Medicine 280
Countries citing papers authored by R.D. Bulbrook
This map shows the geographic impact of R.D. Bulbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.D. Bulbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.D. Bulbrook more than expected).
Fields of papers citing papers by R.D. Bulbrook
This network shows the impact of papers produced by R.D. Bulbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.D. Bulbrook. The network helps show where R.D. Bulbrook may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R.D. Bulbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 2 | |
| 2 | 1988 | 39 | |
| 3 | 1986 | 43 | |
| 4 | 1986 | 25 | |
| 5 | 1984 | 54 | |
| 6 | 1984 | 191 | |
| 7 | 1981 | 21 | |
| 8 | 1978 | 14 | |
| 9 | 1977 | 4 | |
| 10 | 1975 | 21 | |
| 11 | 1973 | 28 | |
| 12 | 1969 | 2 | |
| 13 | 1969 | 4 | |
| 14 | 1967 | 89 | |
| 15 | 1967 | 1 | |
| 16 | The value of urinary steroid estimations in the prediction of response to adrenalectomy or hypophysectomy. | 1965 | 8 |
| 17 | 1964 | 43 | |
| 18 | 1963 | 7 | |
| 19 | 1960 | 21 | |
| 20 | 1955 | 8 |
About R.D. Bulbrook
R.D. Bulbrook is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Oncology, Cancer Research and Biochemistry, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (14 papers), Cancer Risks and Factors (9 papers), Hormonal and reproductive studies (9 papers), Breast Cancer Treatment Studies (6 papers), Hormonal Regulation and Hypertension (4 papers), Breast Lesions and Carcinomas (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Cancer Research (478 citations), Oncology (774 citations), Biochemistry (137 citations), Genetics (528 citations) and Pathology and Forensic Medicine (280 citations). R.D. Bulbrook has collaborated with scholars based in United Kingdom, Netherlands and Denmark. Frequent co-authors include J.L. Hayward, L.V. Crawford, D. Pim, Jack Cuzick, J Boreham, Nicholas Wald, Rosemary R. Millis, M.A. Chaudary, H. G. Kwa and D. Y. Wang. Their work appears in journals such as The Lancet, Journal of Endocrinology, International Journal of Cancer, British Journal of Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.